Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.
about
Modified citrus pectin anti-metastatic properties: one bullet, multiple targetsClinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentGalectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation.B cells and humoral immunity in atherosclerosisModified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.The role of galectin-3 and galectin-3-binding protein in venous thrombosis.Genetic basis of atherosclerosis: insights from mice and humansGalectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D StudiesGalectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells.Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis.Mast cells: pivotal players in cardiovascular diseases.Galectins in acute and chronic inflammation.Personalizing biomarker strategies in heart failure with galectin-3.Molecular biology of atherosclerosis.Nonclassically Secreted Regulators of Angiogenesis.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index.Soluble galectin-3 is associated with premature myocardial infarction.Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.Galectin-3 and new-onset CKD: marker or mediator?Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes.Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome.Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides.Compartment-resolved Proteomic Analysis of Mouse Aorta during Atherosclerotic Plaque Formation Reveals Osteoclast-specific Protein Expression.Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases.
P2860
Q24651188-EE3A2171-3EBF-48B0-934B-04D0BFA6BEBEQ33754895-2DCA2714-3521-4C69-BB34-7241DA5351BBQ33754984-AC4DE2B0-FCA9-4A2E-BA9E-4796D5B381BCQ33789638-3D780A7E-4F5A-4992-A05C-0E3862C8B73CQ33828006-34FD43A3-FECD-4F7B-84A0-DEE6C51800EEQ35026202-903CAB24-A877-4171-A4D8-1C5378DAADC7Q35171280-F31CE897-6F38-47AA-B4CC-7CFB720D7D71Q35975437-EF4B7668-5904-45F1-B7D3-443F00B3B0B0Q36003071-E5602211-94C4-4AFA-AD6D-B23C42019ED6Q36089958-876E59B6-F660-4003-9BBE-A564F5C32528Q36844332-CC8E8901-9A98-43CE-9327-F8F1E1247216Q37638250-552F7AA0-A716-44EB-B522-5F62E8A44A9DQ37983646-DB15D0CA-3AAC-4ACC-AD50-A4689092074EQ38062031-0E054279-D06C-4F50-97C6-9AEAB8277176Q38125279-8717C1C8-BFF7-47D8-BBE7-68ACC32EB711Q38186720-03C2987D-F9C8-4CA5-89E2-639E8D277ECDQ38232998-6BE35B33-EB51-412A-8BEC-56287DAE74BFQ38258947-DA57D1C9-9744-4C3D-8464-E5A4BEDE5C51Q39191329-D3373BAE-057C-469A-A085-E62010DCB902Q40765198-7FD3B916-AC6D-4780-BBFE-983078E8253EQ40908249-3341BEB1-B6FF-4FA2-BF58-F7430694AA88Q41679332-891786A5-1881-4E46-8F17-45A7412C4BCAQ42569059-7BB69573-176C-491B-BBE5-901053D42B5EQ43264211-E842928C-14E5-4D9B-A8CB-CBDBD0CBA077Q43493519-D8AAFCCC-1C08-4C0C-BB0F-CBC797078169Q46682847-30CEFD5F-11D6-448B-8363-F70C51F4CE75Q47326332-973E2E25-DA63-40F9-A1EF-DF9A788A5BECQ47653100-B197BACE-9241-442D-851D-9F78A332A7A5Q47733264-9AF6BC32-70B1-43F9-BCC0-C7D3A7F7ED18
P2860
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@ast
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@en
type
label
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@ast
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@en
prefLabel
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@ast
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@en
P2093
P2860
P1476
Galectin-3 gene inactivation r ...... mation in ApoE-deficient mice.
@en
P2093
Abdul Ghaffar
Eugene P Mayer
Maurice Nachtigal
P2860
P304
P356
10.2353/AJPATH.2008.070348
P407
P577
2007-12-21T00:00:00Z